My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Resolution 2024-069
>
Meetings
>
2024
>
04. April
>
2024-04-16 10:00 AM - Commissioners' Agenda
>
Resolution 2024-069
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/22/2024 9:25:50 AM
Creation date
5/22/2024 9:24:53 AM
Metadata
Fields
Template:
Meeting
Date
4/16/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Resolution Accepting the Johnson & Johnson (Janssen) Washington State State-Wide Opioid Settlement Agreement
Order
7
Placement
Consent Agenda
Row ID
116716
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
130
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
strategies to abate the opioid epidemic described in this opioid abatement shategy list <br />(e.g., health care, primary care, pharmacies, PDMPs, etc.). <br />L. RESEARCH <br />Support opioid abatement research that may include, but is not limited to, the following: <br />1. Monitoring, surveillance, and evaluation of programs and strategies described in this <br />opioid abatement strategy list. <br />2. Research non-opioid treatment of chronic pain. <br />3. Research on improved service delivery for modalities such as SBIRT that demonstrate <br />promising but mixed results in populations vulnerable to opioid use disorders. <br />4. Research on innovative supply'side enforbement efforts such as improved detection of <br />mail-based delivery of synthetic opioids. <br />5. Expanded research on swift/certain/fair models to reduce and deter opioid misuse <br />within criminal justice populations that build upon promising approaches used to <br />address other substances (e.g. Hawaii HOPE and Dakota 2417). <br />6. Research on expanded modalities such as prescription methadone that can expand <br />access to MAT. <br />11 <br />H-25
The URL can be used to link to this page
Your browser does not support the video tag.